In spite of the differences between these 2 studies, they nevertheless congruently demonstrate that damaging mutations in IFN-γ signaling pathway genes are present in a considerable number of melanomas, predisposing them to develop resistance to IFN-γ and ICBs. Here, IFNG is linked to melanoma.